Electra announces a major milestone with the successful validation of its EVE‑Ai™ Adaptive Controls platform, enabling ...

India’s vast patient population and growing healthcare infrastructure has seen it overtake the US as a go-to for clinical trials. But unethical practices worry doctors as the sector expands, writes ...

Training at West Point reinforced the importance of mentorship and the humanistic dimensions of medical practice.

Bristol-Myers Squibb's flurry of dealmaking has continued with en expansion of its partnership with BridgeBio on drugs targeting SHP2, in the hope of combining them with its cancer immunotherapy ...

Bristol-Myers Squibb's deucravacitinib – one of the main pipeline assets in its $74 billion takeover of Celgene in 2019 – has been approved in its first market as a treatment for moderate-to-severe ...

We came across a bullish thesis on Bristol-Myers Squibb Company on Disruptive Analytics’ Substack by Magnus Ofstad. In this ...

A total of 150 students from various public and private schools took part in a special education programme aimed at equipping ...

Meet Mariano Barbacid, the Spanish scientist behind a breakthrough that erased pancreatic cancer in mice and reignited hope ...

From left: Share Registrar Services Asia director Alex Chew, Share Registrar Services Asia director of client management Noor Isaruddin Che Man, BMS Holdings Bhd managing director Ang Kwee Peng and ...

On the heels of the launch of an online direct-to-patient (DTP) program offering discounted Eliquis to certain U.S. patients, Bristol Myers Squibb is putting Sotyku at the center of its next DTP ...

More than 40 years after establishing the first U.S. pharmaceutical joint venture in China, Bristol Myers Squibb is handing over its controlling stake in the business. BMS has inked an agreement to ...